Home » MOODY'S DOWNGRADES BOSTON SCIENTIFIC'S DEBT RATING
MOODY'S DOWNGRADES BOSTON SCIENTIFIC'S DEBT RATING
Moody's Investors Service on Monday cut its ratings on Boston Scientific and said it may cut them again, citing the pending acquisition of Guidant Corp. for about $27.5 billion. Moody's cut Boston Scientific's long-term debt rating one notch to "Baa1," the third-lowest investment-grade rating, from "A3."
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May